Multi drug resistance (MDR) will be one of the most significant public health threats facing humanity in the 21st century.
In order to combat drug resistant organisms global strategies (WHO, EU, US) are in action with screening at the point of need being the name of the game.
At present there is no commercial tool for fast, reliable and cost-effective testing.
The Company’s CYCLE® technology offers a ground-breaking solution for this challenge: a disruptive innovation pioneering next generation diagnostics. It is the first technology to combine the highest degree of automation with semiconductor micro-array chip technology to break down complex diagnostic issues in a fraction of labour, time and cost required so far.